Proteome Systems hits second milestone in the development of a rapid diagnostic test to detect active TB
Proteome Systems announced that its international partner, the Foundation for Innovative New Diagnostics (FIND), has signed off on the second Milestone in its Tuberculosis [TB] diagnostic program. Proteome Systems has discovered and patented TB proteins in human sputum and blood that can be used to diagnose active tuberculosis. There is currently no point-of-care [POC] test to detect TB in its active form. This recent milestone involved producing and using antibodies for the detection of these unique TB proteins in clinical samples.
FIND CEO Giorgio Roscigno said that reaching this second milestone is important particularly as it coincides with World TB Day when partners worldwide are renewing their commitment to rally behind the new ten- year Global Plan to stop TB (2006-2015).
Most read news
Organizations
Other news from the department research and development
These products might interest you

Kjel- / Dist Line by Büchi
Kjel- and Dist Line - steam distillation and Kjeldahl applications
Maximum accuracy and performance for your steam distillation and Kjeldahl applications

AZURA Purifier + LH 2.1 by KNAUER
Preparative Liquid Chromatography - New platform for more throughput
Save time and improve reproducibility during purification

Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous